<!doctype html><html lang=en>
<head>
<meta name=generator content="Hugo 0.89.1">
<title>Stackbit Azimuth Theme</title>
<meta charset=utf-8>
<meta name=viewport content="width=device-width,initial-scale=1">
<meta name=google content="notranslate">
<meta name=description content="The preview of the Azimuth theme">
<meta property="og:type" content="website">
<meta property="og:title" content="Stackbit Azimuth Theme">
<meta property="og:description" content="The preview of the Azimuth theme">
<meta property="og:image" content="https://caring-bee-a536f.netlify.app/images/hero.png">
<meta name=twitter:card content="summary_large_image">
<meta name=twitter:title content="Stackbit Azimuth Theme">
<meta name=twitter:description content="The preview of the Azimuth theme">
<meta name=twitter:image content="https://caring-bee-a536f.netlify.app/images/hero.png">
<link rel=preconnect href=https://fonts.gstatic.com>
<link href="https://fonts.googleapis.com/css2?family=Nunito+Sans:ital,wght@0,400;0,700;1,400;1,700&display=swap" rel=stylesheet>
<link rel=stylesheet href=/assets/css/main.css>
</head>
<body class="palette-blue font-nunito-sans">
<div id=page class=site>
<header id=masthead class="site-header outer">
<div class=inner>
<div class=site-header-inside>
<div class=site-branding>
<h1 class=site-title><a href=/>RCH4 - ALS Drug</a></h1>
</div>
<nav id=main-navigation class=site-navigation aria-label="Main Navigation">
<div class=site-nav-inside>
<button id=menu-close class=menu-toggle><span class=screen-reader-text>Open Menu</span><span class=icon-close aria-hidden=true></span></button>
<ul class=menu>
<li class="menu-item current-menu-item">
<a href=/>
<span>Home</span>
</a>
</li>
<li class=menu-item>
<a href=/about_rch4>
<span>About RCH4</span>
</a>
</li>
<li class=menu-item>
<a href=/rch4_clinical_data>
<span>RCH4 Clinical Data</span>
</a>
</li>
<li class=menu-item>
<a href=/faq>
<span>Faq</span>
</a>
</li>
<li class=menu-item>
<a href=/about>
<span>About Us</span>
</a>
</li>
<li class=menu-item>
<a href=/contact>
<span>Contact Us</span>
</a>
</li>
</ul>
</div>
</nav>
<button id=menu-open class=menu-toggle><span class=screen-reader-text>Close Menu</span><span class=icon-menu aria-hidden=true></span></button>
</div>
</div>
</header>
<main id=content class=site-content>
<section id=hero class="block hero-block bg-accent outer">
<div class=inner>
<div class=grid>
<div class="cell block-preview">
<img src=/images/rch4_chart_single_3years.png alt="App preview">
</div>
<div class="cell block-content">
<h2 class="block-title underline">RCH4 - a new ALS drug</h2>
<div class=block-copy>
<h4 id=a-previously-unknown-problem-protein-has-been-discovered>A previously unknown problem protein has been discovered.</h4>
<h4 id=aspecificallydesigned-new-als-drug-rch4successfully-suppresses-it>A specifically designed new ALS drug, RCH4, successfully suppresses it</h4>
</div>
<div class=block-buttons>
<a href=/about_rch4 class=button>
<span>Learn More</span>
</a>
</div>
</div>
</div>
</div>
</section>
<section id=lorem-ipsum class="block text-block bg-white outer">
<div class=inner>
<div class=grid>
<div class="cell block-content">
<h2 class="block-title underline">Newly diagnosed?</h2>
<div class=block-copy>
<h2 id=if-you-have-been-diagnosed-with-als-and-are-potentially-interested-in-taking-this-newdrug-you-must-first-be-fully-aware-of-the-following>If you have been diagnosed with ALS and are potentially interested in taking this new drug you must first be fully aware of the following</h2>
</div>
</div>
</div>
</div>
</section>
<section id=lorem-ipsum class="block features-block bg-gray outer">
<div class="block-header inner-small">
</div>
<div class=inner>
<div class=block-item>
<div class=grid>
<div class="cell block-preview">
<img src=/images/question.png alt=lorem-ipsum>
</div>
<div class="cell block-content">
<h3 class="block-title underline">Availability is scarse</h3>
<div class=block-copy>
<p>Just because the drug is free does not mean it is cheap and useless. In fact, it is scarce and immensely expensive.</p>
<p>Due to the lack of any external source of funding, we must pay the cost ourselves as a charitable undertaking, therefore the number of patients we can afford to treat is very limited. Accordingly, we avoid publicity or recognition. From time to time when we can afford to treat more PALS, we publish a temporary &lsquo;Contact us&rsquo; page inviting those who may be interested to apply for help.
In every country, we must comply with both their laws and medical ethics. We require some documentation before we could consider helping you which includes an evaluation form, confirmed written diagnosis of ALS or MND from a neurology clinic, a recent blood test, doctor&rsquo;s prescription, Informed Patient Consent - and so on.</p>
<p>You may have issues that would preclude you from using this drug.</p>
</div>
</div>
</div>
</div>
<div class=block-item>
<div class=grid>
<div class="cell block-preview">
<img src=/images/experimental.png alt=lorem-ipsum>
</div>
<div class="cell block-content">
<h3 class="block-title underline">RCH4 is an experimental drug</h3>
<div class=block-copy>
<p>Notwithstanding no side effects over more than eighty patient-treatment years, and slowing or stopping the progression, the current status of this drug is experimental.</p>
<p>We cannot afford to do blinded, placebo-controlled clinical trials. Accordingly, although there exist decades of clinical data indicating notable safety and efficacy over decades of patient-years, in the absence of a 6-month trial (costing $millions) RCH4 must still be considered as an unproven treatment.</p>
</div>
</div>
</div>
</div>
<div class=block-item>
<div class=grid>
<div class="cell block-preview">
<img src=/images/cure.jpeg alt=lorem-ipsum>
</div>
<div class="cell block-content">
<h3 class="block-title underline">RCH4 is not a cure</h3>
<div class=block-copy>
<p>Do not expect a cure - that is extremely unlikely and probably impossible with existing technology. The terms &lsquo;ALS&rsquo; and &lsquo;MND&rsquo; are commonly used as the same thing, whereas, strictly speaking there may be small differences in the definition. There is no clear biomarker (&ldquo;test&rdquo;) for ALS and is difficult to diagnose. In fact, ALS is probably a number of very different diseases that &lsquo;present&rsquo; (the observed symptoms) the same. An example would be Lyme disease. These are referred to as &lsquo;mimics&rsquo; If not entirely different diseases, they are at least different subtypes of the disease. Accordingly, one single drug or treatment is unlikely to be effective for all patients.</p>
<p>Whereas increasing knowledge of the genetic mutations PFN1, SOD1, TLS/FUS, TPD43, C9orf72, etc., adds to the understanding of ALS pathogenesis, it also underlines the heterogeneity of ALS.</p>
</div>
</div>
</div>
</div>
<div class=block-item>
<div class=grid>
<div class="cell block-preview">
<img src=/images/marvelous-oak.jpeg alt=lorem-ipsum>
</div>
<div class="cell block-content">
<h3 class="block-title underline">RCH4 may not work for you</h3>
<div class=block-copy>
<p>Neurodegenerative conditions very rarely improve - if ever. This outlook may now be changing, but there can be no guarantees or assurances of efficacy. Whereas it is imperative that one maintains a positive mental attitude and optimism, likewise, it is most important not to acquire unrealistic expectations.
A respected Professor of Neurology and a Principal Investigator for ALS clinical trials, Dr. Jeremy Shefner, wisely observed: &ldquo;As a community, we are all vulnerable to being overly hopeful and accepting on face value, preliminary data that is expressed positively.”</p>
<p>RCH4 may not help you - people differ in their response to any medication. Whether or not you ask us for treatment is your decision.</p>
<p>On the basis of the current limited available evidence at this time ( > 6,000 doses by 2018), it may or probably slow the statistical progression of your ALS. Some may have views about the implications of living longer. (Refer to the above chart. Also, refer to EFFICACY).</p>
<p>For some PALS, it stops the decline (it stabilizes) of their ALSFRS-R score condition over time. Indeed for some - years. You should also consider the implications of this.</p>
<p>ALS is a highly variable condition and PALS are also highly variable in their response to treatment. Random charts for RCH4 which may be representative of the overall ALS population can be seen HERE.</p>
<p>Although RCH4 has an outstanding safety record and no notable related side effects have ever been reported to date after decades of continual patient-treatment years, there is always the potential for side effects with any drug. You would take RCH4 entirely at your own risk.</p>
</div>
</div>
</div>
</div>
</div>
</section>
<section id=call-to-action class="block cta-block bg-accent outer">
<div class=inner-large>
<div class=grid>
<div class="cell block-content">
<h2 class=block-title>Explore RCH4</h2>
</div>
<div class="cell block-buttons">
<a href=/about_rch4 class=button>
<span>About RCH4</span>
</a>
</div>
</div>
</div>
</section>
</main>
<footer id=colophon class=site-footer>
<div class="footer-top outer">
<div class=inner>
<div class="grid footer-widgets">
<section class="cell widget widget-text">
<h2 class=widget-title>RCH4 Drug</h2>
</section>
<section class="cell widget widget-nav">
<h2 class=widget-title>Company</h2>
<ul class=menu>
<li class=menu-item>
<a href=/about>
<span>About Us</span>
</a>
</li>
<li class=menu-item>
<a href=/contact>
<span>Contact Us</span>
</a>
</li>
</ul>
</section>
<section class="cell widget widget-form">
<h2 class=widget-title>Subscribe</h2>
<p>Register your interest here if the contact us page is not live.</p>
<form name=contactForm id=contactForm action=https://formspree.io/f/mzbylwbr method=post data-netlify=true data-netlify-honeypot=contactForm-bot-field>
<div class=screen-reader-text>
<label id=contactForm-honeypot-label for=contactForm-honeypot>Don't fill this out if you're
human:</label>
<input aria-labelledby=contactForm-honeypot-label id=contactForm-honeypot name=contactForm-bot-field>
</div>
<input aria-labelledby=contactForm-honeypot-label type=hidden name=form-name value=contactForm>
<div class=form-row>
<label id=email-label for=email>Email</label>
<input id=email type=email name=email aria-labelledby=email-label placeholder="Enter email address" required>
</div>
<div class=form-row>
<button type=submit class=button>Register your interest</button>
</div>
</form>
</section>
</div>
</div>
</div>
<div class="footer-bottom outer">
<div class=inner>
<div class=site-info>
&copy; RC Charity. All rights reserved
&nbsp;
</div>
</div>
</div>
</footer>
</div>
<script src=/js/plugins.js></script>
<script src=/js/init.js></script>
<script src=/js/main.js></script>
</body>
</html>